Biogen Stock Moves Lower Despite Beat-and-Raise

BIIB remains down over 32% year-over-year

Digital Content Manager
Jul 20, 2022 at 10:21 AM
facebook twitter linkedin


Biogen Inc (NASDAQ: BIIB) earlier lifted its full-year profit forecast after reporting blowout second-quarter profits of $5.25 per share on revenue of $2.59 billion, both of which came in above Wall Street's expectations, as sales of multiple sclerosis (MS) drug Tecfidera topped estimates. Nevertheless, the equity was last seen down 2.5% to trade at $214.69 amid the company's warnings over increased competition from other generic rivals in the U.S.

The security's latest rally off the $188 region lost steam at the $222 level yesterday. Shares still have support at the 20-day moving average, though, which started guiding BIIB higher in mid-June. Longer term, Biogen stock still carries a hefty 32.2% year-over-year deficit.

Short-term options traders have been relatively optimistic towards Biogen stock, per the equity's Schaeffer's put/call open interest ratio (SOIR) of 0.66, which sits higher than just 17% of readings from the last year. In other words, short-term options traders have rarely been more call-biased.

The good news for those looking to speculate with options is they can be had for a bargain at the moment, per BIIB's Schaeffer's Volatility Index (SVI) of 36%, which sits higher than 18% of readings in its annual range, meaning options traders are pricing in low volatility expectations right now.

 

Stop leaving money on the table with the same old broken options trading approach...

There is no options strategy that more perfectly capitalizes during earnings season better than this simple call and put buying strategy. Perfect for aggressive traders looking to recover their suffering portfolios so far in 2022. With the simplest possible options strategy, Schaeffer's team with 100+ years of options trading excellence, target 200% gains on every single trade. So many trades are being beaten down by the market, but don't be one of them! Don't waste another second... join us right now before the next trade is released! 

 
Best stocks for October and worst stocks for October
 


 


 
Special Offers from Schaeffer's Trading Partners